Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1996
06/27/1996WO1996019574A1 Human interleukin-11 receptor
06/27/1996WO1996019566A1 E2 binding proteins
06/27/1996WO1996019501A1 Modulators of bone cell function and uses thereof
06/27/1996WO1996019499A2 Improved cyclic crf antagonists
06/27/1996WO1996019496A1 Variants of human papilloma virus antigens
06/27/1996WO1996019495A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
06/27/1996WO1996019494A1 Peptides having immunomodulatory activity
06/27/1996WO1996019493A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa
06/27/1996WO1996019492A1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
06/27/1996WO1996019491A1 Heterocyclic keto arginine peptides as thrombin inhibitors
06/27/1996WO1996019483A1 Low molecular weight bicyclic thrombin inhibitors
06/27/1996WO1996019473A1 New derivatives of pyroglutaminic acid, preparation process and applications
06/27/1996WO1996019246A1 Continuous low-dose administration of parathyroid hormone or its agonist
06/27/1996WO1996019244A1 DNA ENCODING A 20 Kd CDK6 INHIBITING PROTEIN
06/27/1996WO1996019238A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
06/27/1996WO1996019236A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES
06/27/1996WO1996019235A1 Enhancement of fetal growth by administration of insulin-like growth factor-1(igf-1)
06/27/1996WO1996019234A1 Mobilisation of haematopoietic cells
06/27/1996WO1996019233A2 Irrigation solution and method for inhibition of pain, inflammation and spasm
06/27/1996WO1996019207A1 Powder formulations containing melezitose as a diluent
06/27/1996WO1996019206A1 Therapeutic preparation for inhalation containing parathyroïd hormone, pth
06/27/1996WO1996019197A1 Aerosol formulations of peptides and proteins
06/27/1996DE4445630A1 Peptide fragments of osteoinductive factor
06/27/1996CA2419289A1 Variants of human papilloma virus antigens
06/27/1996CA2210378A1 Methods and compositions for detecting and treating mycobacterial infections using an ahpcf operon
06/27/1996CA2208773A1 Heterocyclic keto arginine peptides as thrombin inhibitors
06/27/1996CA2208772A1 Low molecular weight bicyclic thrombin inhibitors
06/27/1996CA2208457A1 Human interleukin-11 receptor
06/27/1996CA2208211A1 E2-binding proteins
06/27/1996CA2206803A1 Powder formulations containing melezitose as a diluent
06/27/1996CA2206778A1 Peptides having immunomodulatory activity
06/27/1996CA2206059A1 Improved cyclic crf antagonists
06/27/1996CA2205959A1 Continuous low-dose administration of parathyroid hormone or its agonist
06/26/1996EP0718308A2 Peptide derivatives having binding activity to modified low density lipoprotein
06/26/1996EP0718307A2 Derivatives of 1-oxo-2-(phenylsulfonyl-amino)-pentylpiperidine, their preparation and therapeutic use
06/26/1996EP0718035A2 Method and apparatus for preparing dispersions containing active substances
06/26/1996EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies
06/26/1996EP0717997A1 Use of substance P antagonist in pharmaceutical composition
06/26/1996EP0717753A1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
06/26/1996EP0717752A1 Therapeutic compounds
06/26/1996EP0717751A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t
06/26/1996EP0717750A1 Double-stranded peptide nucleic acids
06/26/1996EP0717736A1 Polar-substituted hydrocarbons
06/26/1996EP0717732A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
06/26/1996EP0717731A1 Difluoro statone antiviral analogs
06/26/1996EP0717636A1 Malaria recombinant poxvirus vaccine
06/26/1996EP0717635A1 Methods for regulating gastrointestinal motility
06/26/1996EP0717634A1 Injectable compositions for soft tissue augmentation
06/26/1996EP0717633A1 Growth differentiation factor-7
06/26/1996EP0717631A1 Immunomodulating compositions from bile
06/26/1996EP0717628A1 Nucleosides with anti-hepatitis b virus activity
06/26/1996EP0717619A1 Treatment of adverse effects associated with administration of extracellular hemoglobin
06/26/1996EP0696201A4 Supplemented and unsupplemented tissue sealants, methods of their production and use
06/26/1996EP0684763A4 Method and apparatus for treating a body fluid.
06/26/1996EP0464135B1 Composition for reducing side effects of a drug
06/26/1996EP0398924B1 Histamine release inhibitory factor and preparations therefore
06/26/1996CN1125479A Ligands for FLT3 receptors
06/26/1996CN1125452A Cellulose binding domain
06/26/1996CN1125451A Biologically active vasopressin analogues
06/26/1996CN1125450A Factor VII-derived peptides
06/26/1996CN1125449A Sialyl Lex analogues as inhibitors of cellular adhesion
06/26/1996CN1125402A Potassium channel blocking compounds and their use
06/26/1996CN1125401A Erythropoietin analog compositions and methods
06/26/1996CN1125400A Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
06/26/1996CN1125399A Immunogenic cancer proteins and peptides and method of use
06/26/1996CN1125395A Compressible enzyme powder
06/26/1996CN1125231A Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions
06/26/1996CN1125141A Solid dispersed substance containing cyclosporin A and its applciation of External use dosage form
06/26/1996CN1032142C Expression of factor seventh and ninth activities in mammalian cells
06/25/1996US5530178 Useful for drug development and for studies of diseases of the immune system
06/25/1996US5530109 DNA encoding glial mitogenic factors
06/25/1996US5530102 Methods and compositions for the direct concentrated delivery of passive immunity
06/25/1996US5530101 Humanized immunoglobulins
06/25/1996US5530097 Human cancer inhibitory peptide amides
06/25/1996US5530096 Diagnosis and therapy of tumors, autoimmune diseases
06/25/1996US5530095 Skin disorders, antitumor agents
06/25/1996US5530094 Gamma retinoic acid receptor
06/25/1996US5529997 Administering for analgesic, hypotensive or diuretic effect or to treat congestive heart failure or irritable bowel syndrome
06/25/1996US5529996 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/25/1996US5529995 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE
06/25/1996US5529991 Oral 1α-hydroxyprevitamin D
06/25/1996US5529986 Water soluble conjugate comprising biologically inert carrier having sulfated glycosaminoglycan molecules anchored to reactive groups thereon by covalent bonds so as to retain antithrombin-binding activity
06/25/1996US5529983 Administering an octapeptide for relief of some aids symptoms
06/25/1996US5529982 Inducing granulocyte production or B cell production in peripheral blood by TGF-β
06/25/1996US5529934 Method for measuring blood procoagulant activity of human leukocyte antigens
06/25/1996US5529914 Photopolymerization of water soluble macromers to form membrane coverings
06/25/1996US5529905 Method of assaying plasma proteins with prothrombin fragments
06/25/1996US5529903 Extraction and cultivation of transformed cells and production of antibodies directed against them
06/25/1996US5529898 Methods of detecting disorders of the central nervous system by detecting autoantibodies which specifically bind ionotropic glutamate receptors
06/25/1996US5529792 Homogenizing chicken embryo or adult bovine brain tissue, centrifuging, applying to cation exchanger, separating active fractions by gel filtration chromatography, purifying by reverse phase liquid chromatography
06/25/1996US5529786 Process and product for treatment of rheumatoid arthritis
06/25/1996US5529785 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
06/25/1996US5529776 Anti-HIV-1 neutralizing antibodies
06/25/1996US5529775 Compositions comprising ONCONASE(™) and cisplatin, melphalan, or doxorubicin HCl
06/25/1996US5529774 In vivo transfer of the HSV-TK gene implanted retroviral producer cells
06/25/1996US5529771 Leukoregulin anti-herpes treatment
06/24/1996CA2166032A1 1-oxo-2-(phenylsulfonylamino)pentylpiperidine; process for preparing them and their use as therapeutic agents
06/20/1996WO1996018900A1 Prevention of protein aggregation
06/20/1996WO1996018741A2 Liposome-mediated transfection of central nervous system cells
06/20/1996WO1996018736A2 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses
1 ... 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 ... 3163